© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Generation Bio Co. (GBIO) shows an Average True Range (ATR) of 0.17 and an Enterprise Value of 230.21M. Its average trading volume over the past 3 months is 65.45K, indicating liquidity. These fundamental metrics provide insight into GBIO's underlying financial health and market activity.
| ATR | 0.17 |
| Enterprise Value | 230.21M |
| Avg Vol (3 Months) | 65.45K |
| Avg Vol (10 Days) | 75.92K |
Generation Bio Co. (GBIO) technical indicators as of January 21, 2026: the SMA 20 is 0.71%, SMA 50 at 3.37%, and SMA 200 at 12.83%. The RSI 14 value is 54.25, suggesting its current momentum. These technical analysis signals help assess GBIO's price trends and potential future movements.
| SMA 20 | 0.71% |
| SMA 50 | 3.37% |
| SMA 200 | 12.83% |
| RSI 14 | 54.25 |
Generation Bio Co. (GBIO) stock performance overview as of January 21, 2026: The 52-week high is $10.2 (currently -46.25% below), and the 52-week low is $3.004 (currently 86.09% above). Over the past year, GBIO's performance is -40.93%, compared to the S&P 500's 9.18% change.
| 52-Week High | 10.2 |
| 52-Week High Chg | -46.25% |
| 52-Week Low | 3.004 |
| 52-Week Low Chg | +86.09% |
| S&P 500 52-Week Chg | 9.18% |
According to market data, Generation Bio Co. (GBIO) stock's recent performance metrics show that over the last month, GBIO is 4.29%, with a Year-to-Date (YTD) performance of -1.58%. Over the past year, the stock has seen a -40.93% change. These figures summarize GBIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 5.7 | 5.77 | 6.48 | 6.95 | 10.2 | 5.7 |
| Low | 5.57 | 5.25 | 4.91 | 3.88 | 3.004 | 5.31 |
| Performance | -0.71% | +4.29% | -9.55% | +32.78% | -40.93% | -1.58% |
According to current financial data, GBIO stock's P/E (TTM) ratio is -0.60, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for GBIO, including P/S (2.46), P/B (0.74), and P/FCF (-0.33), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GBIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.6 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 2.46 | 3.71 | 465.3 | 5.98 |
| P/B (TTM) | 0.74 | -0.71 | 9.64 | 5.86 |
| P/FCF (TTM) | -0.33 | -8.68 | -332.17 | 34.34 |